FDA approves ProBeam Proton Therapy System-Varian
Varian Medical Systems has received FDA 510(k) clearance for its updated ProBeam proton therapy system. Varian's ProBeam system gives clinicians options for delivering dose precisely in order to minimize dose to healthy tissue in the course of delivering proton therapy treatments for cancer. Its scanning beam technology enables intensity-modulated proton therapy (IMPT) by modulating dose levels on a spot-by-spot basis throughout the treatment area.
One system is operating in Germany but Varian also has contracts to install ProBeam systems at six sites: four in the United States, one in Saudi Arabia, and one in Russia.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.